Literature DB >> 25133035

Helicobacter pylori as a risk factor for central serous chorioretinopathy: Literature review.

Aránzazu Mateo-Montoya1, Martine Mauget-Faÿse1.   

Abstract

Helicobacter pylori (H. pylori), a Gram-negative bacterium, is one of the most frequent causes of gastrointestinal infections worldwide. It has been associated as a pathogen for the human body with many systemic diseases, including different eye diseases. We will focus on a specific eye disease called idiopathic central serous chorioretinopathy (ICSCR). This disease is characterized by a serous detachment of the neurosensory retina in the macular region, which affects the vision to different degrees. Currently, the pathophysiology of ICSCR is not clear and there is no effective treatment. However, several potential risk factors have been elucidated. One of the factors that has more frequently been associated with ICSCR is stress. As H. pylori was identified as a possible etiological factor for occlusive arterial diseases in young people who were particularly stressed, it was thought that H. pylori might also be present in ICSCR. Therefore, some physicians started to test its presence in patents with ICSCR. If H. pylori happened to be associated with ICSCR, the treatment of gastrointestinal infection could also improve visual symptoms and help to remediate this eye disease. Although H. pylori is highly prevalent in the general population, a true correlation seems to exist. We present a review on the relationship between ICSCR and H. pylori.

Entities:  

Keywords:  Eye disease; Helicobacter pylori; Idiopathic central serous chorioretinopathy; Occlusive arterial disease; Retina

Year:  2014        PMID: 25133035      PMCID: PMC4133532          DOI: 10.4291/wjgp.v5.i3.355

Source DB:  PubMed          Journal:  World J Gastrointest Pathophysiol        ISSN: 2150-5330


  33 in total

1.  Helicobacter pylori-related extradigestive diseases and effects of eradication therapy.

Authors:  E Carloni; F Cremonini; S Di Caro; C Padalino; L Gerardino; A Santoliquido; S Colasanti; P Pola; A Gasbarrini
Journal:  Dig Liver Dis       Date:  2000-12       Impact factor: 4.088

2.  Expanding the spectrum of Helicobacter pylori-associated diseases.

Authors:  R Zbinden
Journal:  Infection       Date:  2005-04       Impact factor: 3.553

3.  Helicobacter pylori: an underestimated factor in acute anterior uveitis and spondyloarthropathies?

Authors:  Ljiljana Otasevic; Gordana Zlatanovic; Anka Stanojevic-Paovic; Biljana Miljkovic-Selimovic; Marina Dinic; Jasmina Djordjevic-Jocic; Aleksandra Stankovic
Journal:  Ophthalmologica       Date:  2007       Impact factor: 3.250

4.  Central serous chorioretinopathy associated with retinitis pigmentosa.

Authors:  Yosef Dorenboim; Uri Rehany; Shimon Rumelt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-03-02       Impact factor: 3.117

5.  Risk factors for central serous chorioretinopathy: a case-control study.

Authors:  Robert Haimovici; Sean Koh; David R Gagnon; Todd Lehrfeld; Sarah Wellik
Journal:  Ophthalmology       Date:  2004-02       Impact factor: 12.079

Review 6.  Molecular mimicry in atherosclerosis: a role for heat shock proteins in immunisation.

Authors:  David J Lamb; Wafaa El-Sankary; Gordon A A Ferns
Journal:  Atherosclerosis       Date:  2003-04       Impact factor: 5.162

7.  [Helicobacter pylori in central serous chorioretinopathy and diffuse retinal epitheliopathy. Results of the first prospective pilot study].

Authors:  M Mauget-Faÿsse; L Kodjikian; M Quaranta; D Ben Ezra; C Trepsat; F Mion; F Mégraud
Journal:  J Fr Ophtalmol       Date:  2002-12       Impact factor: 0.818

8.  Cystoid macular degeneration in chronic central serous chorioretinopathy.

Authors:  Tomohiro Iida; Lawrence A Yannuzzi; Richard F Spaide; Natalie Borodoker; Cynthia A Carvalho; Silvana Negrao
Journal:  Retina       Date:  2003-02       Impact factor: 4.256

Review 9.  Helicobacter pylori infection and respiratory diseases: a review.

Authors:  Anastasios Roussos; Nikiforos Philippou; Konstantinos I Gourgoulianis
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742

10.  The effect of eradicating Helicobacter pylori on idiopathic central serous chorioretinopathy patients.

Authors:  Yalong Dang; Yalin Mu; Manli Zhao; Lin Li; Yaning Guo; Yu Zhu
Journal:  Ther Clin Risk Manag       Date:  2013-09-02       Impact factor: 2.423

View more
  4 in total

1.  The association of Helicobacter pylori with choroidal and retinal nerve fiber layer thickness.

Authors:  Mehmet Erol Can; Fatma Efe Kaplan; Mehmet Murat Uzel; Hasan Kiziltoprak; Mustafa Cagri Ergun; Mustafa Koc; Gülcin Simsek
Journal:  Int Ophthalmol       Date:  2017-08-05       Impact factor: 2.031

2.  Genome-wide association analyses identify two susceptibility loci for pachychoroid disease central serous chorioretinopathy.

Authors:  Kenji Yamashiro; Akitaka Tsujikawa; Yoshikatsu Hosoda; Masahiro Miyake; Rosa L Schellevis; Camiel J F Boon; Carel B Hoyng; Akiko Miki; Akira Meguro; Yoichi Sakurada; Seigo Yoneyama; Yukari Takasago; Masayuki Hata; Yuki Muraoka; Hideo Nakanishi; Akio Oishi; Sotaro Ooto; Hiroshi Tamura; Akihito Uji; Manabu Miyata; Ayako Takahashi; Naoko Ueda-Arakawa; Atsushi Tajima; Takehiro Sato; Nobuhisa Mizuki; Chieko Shiragami; Tomohiro Iida; Chiea Chuen Khor; Tien Yin Wong; Ryo Yamada; Shigeru Honda; Eiko K de Jong; Anneke I den Hollander; Fumihiko Matsuda
Journal:  Commun Biol       Date:  2019-12-12

3.  Mineralocorticoid Receptor Antagonist Treatment for Steroid-Induced Central Serous Chorioretinopathy Patients with Continuous Systemic Steroid Treatment.

Authors:  Jin Young Kim; Ju Byung Chae; Jisoo Kim; Dong Yoon Kim
Journal:  J Ophthalmol       Date:  2018-07-22       Impact factor: 1.909

4.  Clinical Characteristics and Multimodal Imaging Findings of Central Serous Chorioretinopathy in Women versus Men.

Authors:  Elodie Bousquet; Héloïse Torres-Villaros; Julien Provost; Martine Elalouf; Anthony Gigon; Irmela Mantel; Aurélie Timsit; Francine Behar-Cohen
Journal:  J Clin Med       Date:  2022-03-19       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.